Epinephrine
18 NDCs across 8 manufacturers|10 Generic,8 Brand
Epinephrine is used to treat airway obstruction, anaphylaxis, bradycardia, bronchial spasm, open-angle glaucoma and heart arrest, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved May 23, 1984. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $120 million on Epinephrine across 583,000 claims for 463,000 beneficiaries.
Epinephrine is available as 18 NDCs from 8 manufacturers (10 generic, 8 brand), with NADAC prices from $112.99 to $360.40 per EA — the most expensive product costs about 3.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
22 Epinephrine presentations are currently listed in FDA's drug shortage database (first posted Feb 22, 2012). Shortages can move NADAC prices in the following weeks.
Total NDCs
18
10G / 8B
Manufacturers
8
competing in market
Price Spread
$112.99 – $360.40
per EA, 15 of 18 NDCs
7d Activity
avg -0.4% WoW · of 18 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
8 manufacturers producing EPINEPHRINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
NEFFY 1 MG/0.1 ML NASAL SPRAY | $360.3990 per EA | +0.04% |
NEFFY 2 MG/0.1 ML NASAL SPRAY | $359.5478 per EA | -0.03% |
AUVI-Q 0.15 MG AUTO-INJECTOR | $309.8510 per EA | — |
AUVI-Q 0.1 MG AUTO-INJECTOR | $309.5523 per EA | — |
AUVI-Q 0.3 MG AUTO-INJECTOR | $309.3757 per EA | — |
EPIPEN JR 2-PAK 0.15 MG INJCTR | $290.6380 per EA | — |
EPIPEN 2-PAK 0.3 MG AUTO-INJCT | $289.9600 per EA | — |
EPINEPHRINE 0.15 MG AUTO-INJCT | $141.8538 per EA | -0.21% |
EPINEPHRINE 0.3 MG AUTO-INJECT | $141.1397 per EA | -0.04% |
EPINEPHRINE 0.3 MG AUTO-INJECT | $132.8287 per EA | -0.91% |
EPINEPHRINE 0.15 MG AUTO-INJCT | $127.1998 per EA | -0.99% |
EPINEPHRINE 0.15 MG AUTO-INJCT | $118.5934 per EA | -0.94% |
EPINEPHRINE 0.15 MG AUTO-INJCT | $118.5934 per EA | -0.94% |
EPINEPHRINE 0.3 MG AUTO-INJECT | $112.9870 per EA | -0.63% |
EPINEPHRINE 0.3 MG AUTO-INJECT | $112.9870 per EA | -0.63% |
ADRENALIN 1 MG/ML VIAL | $7.7955 per ML | — |
EPINEPHRINE 1 MG/10 ML LUERJET | $1.2263 per ML | +1.11% |
EPINEPHRINE 1 MG/10 ML ABBOJCT | $1.1940 per ML | — |
Frequently Asked Questions
What is Epinephrine used to treat?
Epinephrine is used to treat airway obstruction, anaphylaxis, bradycardia, bronchial spasm, open-angle glaucoma and heart arrest, per the National Library of Medicine's MED-RT classification.
When did Epinephrine become available as a generic?
FDA approved the first generic Epinephrine (ANDA) on May 23, 1984. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Epinephrine?
In 2024, Medicare Part D spent $120 million on Epinephrine across 583,000 claims for 463,000 beneficiaries.
Is Epinephrine in shortage?
Yes — FDA's drug shortage database currently lists 22 Epinephrine presentations with status "Current", first posted Feb 22, 2012.
How many Epinephrine products are on the market?
The Epinephrine drug market contains 18 NDCs from 8 manufacturers — 10 generic and 8 brand products.
What is the price range for Epinephrine?
NADAC reference prices for Epinephrine range from $112.9870 to $360.3990 per EA — the most expensive product costs about 3.2× the cheapest. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Epinephrine cheaper than brand?
The average generic NADAC for Epinephrine is $125.7729 per EA, versus $318.4748 for brand-labeled products — brand versions average about 2.5× the generic price.
Which manufacturers make Epinephrine?
8 manufacturers list Epinephrine in NADAC. Ranked by number of NDCs, the largest are Viatris Specialty LLC (4), Amneal Pharmaceuticals of New York LLC (4), kaleo, Inc (3), ARS Pharmaceuticals Operations, Inc. (2), Teva Pharmaceuticals USA Inc. (2).
How has the price of Epinephrine changed recently?
Over the past 7 days, 6 Epinephrine NDCs rose and 27 fell, with a market-wide average change of -0.4%.